Navigation Links
SNM awards $300,000 to support molecular imaging research
Date:7/14/2008

Yale University was named the recipient of the $100,000 SNM Molecular Imaging Research Grant for Junior Medical Faculty for a research project using SPECT to study neuroinflammation and depression during treatment of patients with hepatitis C. This grant provides a junior faculty member who has clinical responsibilities with salary support to fund their research.

Peter Dimetri Olcott from Stanford University and Hyo-eun Carrie Bhang from the Johns Hopkins School of Medicine were recognized as recipients of the SNM Postdoctoral Molecular Imaging Scholar Program for their work in whole-body clinical PET/MR systems and therapeutic systems for cancer, respectively. These individual $40,000 grants will support research endeavors for the development and integration of molecular imaging approaches into the investigation of the fundamental causes of disease.

Sepideh Shokouhi from Vanderbilt University Medical Center and Vania E. Kenanova from the University of California, Los Angeles, are recipients of the SNM Postdoctoral Molecular Imaging Scholar Program, which provides $60,000 for two years of research at institutions with established molecular imaging programs. Their respective research will focus on Alzheimer's disease and the targeted delivery of imaging or therapeutic agents.

"We are truly thrilled to offer these awards and deeply appreciative of the support of the donors who make this ground-breaking research a reality," said VanBrocklin.


'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. The American Society of Plant Biologists announces 2007 awards
2. Singapore National Science and Technology Awards
3. Homeland Security awards 2 grants to Rutgers for nuclear threat detection
4. NIH awards nearly $23M to University of Chicago for translational research
5. NIH awards researcher $1.5 million new innovator grant for fruit-fly studies of prion proteins
6. PETA awards $120,000 to Duluth Foundation for advancing non-animal tests
7. NIH awards UC $9 million grant to improve patient point-of-care technologies
8. NIST announces 56 new awards for innovative technology research and development
9. USP awards verified mark to Dr. Reddys Laboratories, Ltd. ingredients
10. Simons Foundation awards Emory scientists $3M for autism gene research
11. NIH grants $33 M in institutional development awards to 3 states

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/4/2009)...t. 26 BIO-key Internatio...finger-based biometric identification software is ... the AABB TXPO conference being held at the New Or...IO-key will provide hands-on product demonstration...y in booth #424. Also, at 5 PM on Monday, October ...
(Date:11/4/2009)...f., Nov. 4 GenVault Corporation (C....D., Ph.D., has joined its Board of Directors. Dr...e Salk Institute, is an acclaimed physician-scient...alk Institute, Dr. Brody served as president of Th... National Academy of Engineering and the Institute...
(Date:11/3/2009)...L (November 4, 2009) For more than 25 years, all ...( Strombus gigas ) have been unsuccessfuluntil now...g techniques to produce beaded (nucleated) and non...been developed by scientists from Florida Atlantic...e (HBOI). With less than two years of research and...
Breaking Biology News(10 mins):BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 1Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 2Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 4Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 5Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 6Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 1Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 2Simcere Pharmaceutical Group Announces Collaboration with OSI Pharmaceuticals 5582 3The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 1The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 2The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 14535 3
... dwelling in ocean-bottom sediments appears in lab...ant multiple myeloma cells, and potentially with l...Farber Cancer Institute researchers in the Novembe...d, NPI-0052, has been found to block or inhibit ca...The proteasome work as a cell,s "garbage disposal,...
...s system must coordinate a laundry list of signals...y level, food preferences, and metabolic need, whi...ality of available food, determined by its smell a...phila have traced the path of olfactory signals be...h set off neurons that signal the antennal lobe of...
...air birth defectsResearchers at Children,s Hospita...truct defective tracheas (windpipes) in fetal lamb...ow sections of cartilage tube, and then implanting... the womb. , The tracheal repair technique is one ... at Children,s that use the fetus,s own cells, dra...
Other Biology News:Compound from marine bacteria shows potential as multiple myeloma therapy 2Compound from marine bacteria shows potential as multiple myeloma therapy 3How Fruitflies Know It's Time for Lunch 2How Fruitflies Know It's Time for Lunch 3Cells from amniotic fluid used to tissue-engineer a new trachea 2Cells from amniotic fluid used to tissue-engineer a new trachea 3
(Date:11/5/2009)... Neb., Nov. 5 Transgenom...d financial results for the quarter ended Septembe...esented in the tables that follow. ,, Third Qu...of $366,000 or $0.01 per share for the third quart...r $0.01 per share for the third quarter of 2008. ...
(Date:11/5/2009)...EGO, CA, November 5, 2009 /PRNewswire-FirstCall/ -...d on using proprietary taste receptor-based techno...e food, beverage, and ingredient supply industries...inancial results for the third quarter ended Septe... third quarter of 2009, compared to $4.0 million f...
(Date:11/5/2009)... Drug safety specialty firm BioSoteri...nd Informatics earned the Certified Professional i...l from the American Society for Training and Devel...lewell has more than fifteen years of medical comm... is responsible for the development of the company...
(Date:11/4/2009)... The Human Anthrax Vaccine Program mu...eted the feature film "A Call to Arms:2009 Ed...y "Fatal Immunity: The Human Anthrax Vaccine ...nd present danger of top secret government science...h no accountability to its victims. It is availab...
Breaking Biology Technology:Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 2Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 3Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 4Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 5Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 6Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide Licensing 7
... Md., Oct. 24 MedImmune, Inc. announced,today tha...unty (CVC-MC),has recognized the company for its e... MedImmune received the CVC-MC,s 2007 Corporate Vo...n,s leading biotechnology company, MedImmune is pr...hose employees strive to give,back to the communit...
...,000 Additional Votes "FOR" Required for Integra M...c.,(NASDAQ: ISOT ) ("IsoTis"), an orthobiologics ... special meeting of stockholders again, to October...Integra LifeSciences Holdings,Corporation (NASDAQ:...plan of,merger dated as of August 6, 2007. The sp...
...la., Oct. 24 Nabi,Biopharmaceuticals (Nasdaq: NA...er 18, 2007, it commenced mailing its definitive p... proposed sale of its biologics strategic,business... to Biotest,Pharmaceuticals Corporation, a wholly ...t purchase agreement dated as of September 11, 200...
Other Biology Technology:IsoTis Adjourns Special Meeting to October 26, 2007 2IsoTis Adjourns Special Meeting to October 26, 2007 3IsoTis Adjourns Special Meeting to October 26, 2007 4Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement and Release Date of Third Quarter 2007 Financial Results 2Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement and Release Date of Third Quarter 2007 Financial Results 3
Stackable Refrigerated Shaker, 230V, 50 Hz from Thermo Scientific
18" 18" Dedicated Platform with (8) 1l Clips from Thermo Scientific
29.5" 18" Dedicated Platform with (61) 125ml Clips, for Stackable Shakers from Thermo Scientific
PCR Workstation from Thermo Scientific
Biology Products: